SCD and cancer: A missense polymorphism (rs2234970, A/C, M224L) of SCD1 has been detected with high occurrence (minor allele frequency: 40%), and it has been investigated in association studies regarding metabolic and cardiovascular diseases as well as different cancer types with conflicting results so far.